Kennedy injects uncertainty into big pharma

Kennedy injects uncertainty into big pharma

Up next

Reform UK mega-donors stir controversy

The Venezuelan government and the country’s opposition are close to reaching an agreement to transfer the central bank’s gold reserves, critics are scrutinising donations to UK Reform by crypto billionaires Ben Delo and Christopher Harborne, and Glencore has suspended one of its ...  Show more

Fed interest rate rises are back

The Federal Reserve has raised rates for the first time since 2023, and the EU has asked China to restrict exports of hybrid cars as part of a deal to prevent a trade war. Plus, AI has revolutionized warfare.Mentioned in this podcast:Federal Reserve defies Donald Trump with first ...  Show more

Recommended Episodes

Epstein Saga Continues, Trump Launches Distractions, and Cuomo Relaunches Campaign
Pivot

Kara and Scott discuss whether Trump will fire Fed Chair Jerome Powell, and all of the administration's efforts to distract from the Epstein scandal. Elon Musk’s Grok scores a contract with the Defense Department, and Andrew Cuomo will officially run as an independent in the NYC ...  Show more

Trump's Pump and Dump (feat. Sen. Raphael Warnock)
Pod Save America

Donald Trump prepares to pay a $175 million bond, Truth Social goes public and a date is set for the first ever criminal trial of a former president. Mike Johnson faces a motion to vacate his speakership while his House majority seems to be disappearing. Bibi Netanyahu beefs w ...

  Show more

China Optimism Fuels Stocks, Iranian President's Warning & Starmer Embraces Unpopularity
Bloomberg Daybreak: Europe Edition

Your morning briefing, the business news you need in just 15 minutes. On today's podcast: (1) China’s central bank lowered the interest rate charged on its one-year policy loans by the most on record, kicking off a sweeping program to revive confidence in the world’s second-large ...  Show more

New “TrumpRx” to Lower Drug Prices & Spotify Drops One CEO for Two
Morning Brew Daily

Episode 682: Neal and Toby talk about Trump’s newly launched “TrumpRx” program designed to make more prescription drugs affordable. Then, the federal EV tax credit has officially ended, and some believe a drastic slowdown in EV sales. Also, Amazon overhauls its hardware and some ...  Show more